BioCryst Pharmaceuticals | BCRX - EPS Earnings Per Share


BioCryst Pharmaceuticals reported $-0.13 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
Chugai Pharma JPY 78.03 10.45 Dec/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novavax USD -0.76 1.76 Sep/2024
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025